A novel gene immunotherapy for chronic HBV and HDV: blocking viral entry by neutralizing PreS1 antibodies

被引：0

作者：

Frelin, L. ^{[1
]}

Maravelia, P. ^{[1
]}

Jagya, N. ^{[1
]}

Verch, G. ^{[2
]}

Ni, Y. ^{[2
]}

Perez, N. C. ^{[1
]}

Portoles, I. ^{[1
]}

Urban, S. ^{[2
]}

Saellberg, M. ^{[1
]}

机构：

[1] Karolinska Inst, Lab Med, Stockholm, Sweden

[2] Heidelberg Univ, Mol Virol, Heidelberg, Germany

来源：

JOURNAL OF VIRAL HEPATITIS | 2018年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

O-009

引用

页码：9 / 10

页数：2

共 40 条

[31] SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry
Bai, Ru
Zhang, Xing-Jie
Li, Yan-Li
Liu, Jing-Ping
Zhang, Hong-Bin
Xiao, Wei-Lie
Pu, Jian-Xin
Sun, Han-Dong
Zheng, Yong-Tang
Liu, Li-Xin
BMC MICROBIOLOGY, 2015, 15
[32] SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry
Ru Bai
Xing-Jie Zhang
Yan-Li Li
Jing-Ping Liu
Hong-Bin Zhang
Wei-Lie Xiao
Jian-Xin Pu
Han-Dong Sun
Yong-Tang Zheng
Li-Xin Liu
BMC Microbiology, 15
[33] A non-viral CRISPR/Cas9 gene-editing approach to express anti-HIV broadly-neutralizing antibodies in human B cells for HIV immunotherapy
Doms, J.
Fournier, C.
Gosseye, A.
Godot, V.
Fenwick, C.
Levy, Y.
Pantaleo, G.
Galy, A.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A158 - A158
[34] Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients
Wungu, Citrawati Dyah Kencono
Amin, Mochamad
Ruslan, S. Eriaty N.
Purwono, Priyo Budi
Kholili, Ulfa
Maimunah, Ummi
Setiawan, Poernomo Boedi
Lusida, Maria Inge
Soetjipto, Soetjipto
Handajani, Retno
BIOMEDICAL REPORTS, 2019, 11 (04) : 145 - 153
[35] EFFICIENT CROSS-NEUTRALIZATION OF HEPATITIS C VIRUS INFECTION BY MONOCLONAL ANTI-CLAUDIN 1 ANTIBODIES: A NOVEL ANTIVIRAL STRATEGY TARGETING VIRAL ENTRY
Krieger, Sophie E.
Fofana, Isabel
Soulier, Eric
Schuster, Catherine
Thompson, John
Grunert, Fritz
Baumert, Thomas F.
HEPATOLOGY, 2009, 50 (04) : 410A - 410A
[36] SERUM ANTI-E1E2 D32.10 NEUTRALIZING ANTIBODIES PREDICT VIRAL CLEARANCE KINETICS DURING STANDARD THERAPY OF CHRONIC HCV INFECTION
Arnaud, C.
Ndongo-Thiam, N.
Berthillon, P.
Spaziante, M.
Pradat, P.
Bordes, I.
Maynard, M.
Taliani, G.
Trepo, C.
Petit, M. -A.
JOURNAL OF HEPATOLOGY, 2012, 56 : S357 - S357
[37] W381Ter:: Novel mutation in the coding sequence of the acid β-glucosidase gene of a Type 1 Gaucher patient who developed neutralizing antibodies.
Ponce, E
Grabowski, GA
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 287 - 287
[38] Novel mode of viral mutation "replacement mutation" with hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis patient with HBV genotype E
Fujiwara, K
Tanaka, Y
Orito, E
Kato, T
Paulon, E
Ueda, R
Naoumov, NV
Mizokami, M
HEPATOLOGY, 2005, 42 (04) : 706A - 707A
[39] No amino acid substitution in HBV PreS1, HDAg, or NTCP associated with suboptimal response to bulevirtide in combination with pegylated interferon alfa-2a treatment in participants with chronic hepatitis delta: results from MYR204 a phase 2b study
Liu, Yang
Chang, Silvia
Xu, Simin
Martin, Ross
Aeschbacher, Thomas
Manhas, Savrina
Mateo, Roberto
May, Lindsey
Han, Dong
Yazdi, Tahmineh
Marceau, Caleb
Richards, Christopher
Ho, Pui Yan
Li, Chunfeng
Martinez, Clarissa
Peinovich, Nadine
Lopez, Andrew
Manuilov, Dmitry
Mercier, Renee-Claude
Lau, Audrey H.
Asselah, Tarik
Zoulim, Fabien
Maiorova, Evguenia
Mo, Hongmei
JOURNAL OF HEPATOLOGY, 2024, 80 : S737 - S738
[40] Phase 1b clinical trial of TG1050 a novel HBV-targeted immunotherapy in NUC suppressed chronic hepatitis B (CHB) patients: safety and early immunological data following single administration
Sprinzl, Martin F.
Fournier, Claire
Leroy, Vincent
Pol, Stanislas
Habersetzer, Francois
Thimme, Robert
Ma, Mang M.
Inchauspe, Genevieve
Halluard, Celine
Bendjama, Kaidre
Brandely, Maud
Zoulim, Fabien
HEPATOLOGY, 2017, 66 : 483A - 484A

← 1 2 3 4 →